These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 7252203)

  • 1. Fever in Indian kala-azar: the type and the delayed response to therapy.
    Maitra SB; Mukherjee A; Sarkar M; Hati AK
    J Indian Med Assoc; 1981 Jan; 76(1-2):25-6. PubMed ID: 7252203
    [No Abstract]   [Full Text] [Related]  

  • 2. Demonstration of Leishmania parasites in skin lesions of Indian post kala-azar dermal leishmaniasis (PKDL) cases.
    Sharma MC; Gupta AK; Verma N; Das VN; Saran R; Kar SK
    J Commun Dis; 2000 Mar; 32(1):67-8. PubMed ID: 11129569
    [No Abstract]   [Full Text] [Related]  

  • 3. Noninvasive management of Indian visceral leishmaniasis: clinical application of diagnosis by K39 antigen strip testing at a kala-azar referral unit.
    Sundar S; Sahu M; Mehta H; Gupta A; Kohli U; Rai M; Berman JD; Murray HW
    Clin Infect Dis; 2002 Sep; 35(5):581-6. PubMed ID: 12173133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological response in Indian kala-azar.
    Aikat BK; Pathania AG; Sehgal S; Bhattacharya PK; Dutta U; Pasricha N; Singh S; Parmar RS; Sahaya S; Prasad LS
    Indian J Med Res; 1979 Oct; 70():583-91. PubMed ID: 396234
    [No Abstract]   [Full Text] [Related]  

  • 5. [Fever of unknown origin due to sporadic kala-azar].
    Buhl H; Meiser RJ; Pappas A
    Med Welt; 1971 May; 22():917-9. PubMed ID: 5088607
    [No Abstract]   [Full Text] [Related]  

  • 6. Orally effective drugs for kala-azar (visceral leishmaniasis): focus on miltefosine and sitamaquine.
    Sangraula H; Sharma KK; Rijal S; Dwivedi S; Koirala S
    J Assoc Physicians India; 2003 Jul; 51():686-90. PubMed ID: 14621038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fever, hepatosplenomegaly and hypergammaglobulinemia with leuko- and thrombopenia in kala-azar in a child].
    Peltola H; Rapola J; Jokipii L
    Duodecim; 1980; 96(17):1145-52. PubMed ID: 7249951
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinico-hematological characteristics in patients with kala azar. A study from north-west India.
    Marwaha N; Sarode R; Gupta RK; Garewal G; Dash S
    Trop Geogr Med; 1991 Oct; 43(4):357-62. PubMed ID: 1812600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short communication: post-kala-azar dermal leishmaniasis--an appraisal.
    Ramesh V; Singh R; Salotra P
    Trop Med Int Health; 2007 Jul; 12(7):848-51. PubMed ID: 17596251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-kala-azar dermal leishmaniasis and visceral leishmaniasis in a child--or is it para-kala-azar dermal leishmaniasis?
    Mendiratta V; Chander R
    Int J Dermatol; 2009 Sep; 48(9):1027-8. PubMed ID: 19703001
    [No Abstract]   [Full Text] [Related]  

  • 11. Epidemiology of visceral leishmaniasis in India.
    Bora D
    Natl Med J India; 1999; 12(2):62-8. PubMed ID: 10416321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for Indian kala-azar.
    Ranjan A; Sur D; Singh VP; Siddique NA; Manna B; Lal CS; Sinha PK; Kishore K; Bhattacharya SK
    Am J Trop Med Hyg; 2005 Jul; 73(1):74-8. PubMed ID: 16014837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of liposomal amphotericin B (AmBisome) for visceral leishmaniasis in endemic developing countries.
    Berman JD; Badaro R; Thakur CP; Wasunna KM; Behbehani K; Davidson R; Kuzoe F; Pang L; Weerasuriya K; Bryceson AD
    Bull World Health Organ; 1998; 76(1):25-32. PubMed ID: 9615494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High prevalence of functional liver derangement in visceral leishmaniasis at an Indian tertiary care center.
    Mathur P; Samantaray JC; Samanta P
    Clin Gastroenterol Hepatol; 2008 Oct; 6(10):1170-2. PubMed ID: 18619918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-kala-azar dermal leishmaniasis.
    Baghestani S; Handjani F; Sodeifi M; Kumar PV
    Eur J Dermatol; 1998 Jun; 8(4):277-9. PubMed ID: 9649686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knowledge, attitude, and practices related to Kala-azar in a rural area of Bihar state, India.
    Singh SP; Reddy DC; Mishra RN; Sundar S
    Am J Trop Med Hyg; 2006 Sep; 75(3):505-8. PubMed ID: 16968930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fulminating strongyloidiasis complicating Indian kala-azar.
    Nandy A; Addy M; Patra P; Bandyopashyay AK
    Trop Geogr Med; 1995; 47(3):139-41. PubMed ID: 7483007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased levels of interleukin-10 and IgG3 are hallmarks of Indian post-kala-azar dermal leishmaniasis.
    Ganguly S; Das NK; Panja M; Pal S; Modak D; Rahaman M; Mallik S; Guha SK; Pramanik N; Goswami R; Barbhuiya JN; Saha B; Chatterjee M
    J Infect Dis; 2008 Jun; 197(12):1762-71. PubMed ID: 18444882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphadenopathy in Indian Kala-azar and Dermal leishmanoid.
    Sen Gupta PC; Mukherjee AM
    Indian J Pathol Bacteriol; 1968 Jul; 11(3):172-8. PubMed ID: 5760887
    [No Abstract]   [Full Text] [Related]  

  • 20. Incidence of HIV infection in resistant cases of Indian kala-azar.
    Jha TK; Singh NK; Thakur CP; Singh TK
    J Assoc Physicians India; 1994 Mar; 42(3):263. PubMed ID: 7860533
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.